MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Essential tremor(ET)"

  • MDS Virtual Congress 2021

    Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS trial): safety and efficacy proof of principle

    C. Iorio-Morin, K. Yamamoto, C. Sarica, A. Zemmar, M. Levesque, S. Brisebois, J. Germann, A. Loh, A. Boutet, G. Elias, P. Azevedo, E. Adam, U. Patel, M. Lenis, S. Kalia, M. Hodaie, A. Fasano, A. Lozano (Sherbrooke, Canada)

    Objective: The goal of this study was to assess the feasibility, safety and efficacy of staged, bilateral, focused ultrasound thalamotomies for essential tremor. Background: Essential…
  • MDS Virtual Congress 2021

    Comparative connectivity correlates of dystonic and essential tremor deep brain stimulation

    T. Tsuboi, J. Wong, R. Eisinger, L. Okromelidze, M. Burns, A. Ramirez-Zamora, L. Almeida, A. Wagle Shukla, K. Foote, M. Okun, S. Grewal, M. Katsuno, E. Middlebrooks (Gainesville, USA)

    Objective: To analyze the pathophysiology of dystonic tremor (DT) and essential tremor (ET) and to reveal the optimal deep brain stimulation (DBS) target for these…
  • MDS Virtual Congress 2021

    Deep Brain Stimulation Surgery and Clinical Characteristics of Essential Tremor in a Cohort of Veterans

    F. Jamal, I. Noorbhai, G. Jackson, A. Sarwar (Houston, USA)

    Objective: To review clinical characteristics of essential tremor (ET) in patients who underwent deep brain stimulation (DBS) surgery. Background: DBS surgery is an effective treatment…
  • MDS Virtual Congress 2020

    Delayed lesion adverse effects of gamma knife radiosurgical thalamotomy for essential tremor

    A. Patel, J. Gerrard (New Haven, CT, USA)

    Objective: To describe a novel case of gamma knife radiosurgical (GKRS) thalamotomy for treatment of refractory essential tremor (ET) with delayed onset adverse effects due…
  • MDS Virtual Congress 2020

    Satisfaction and impact on quality of life in patients with essential tremor treated with High Intensity Focused Ultrasound (HIFU) thalamotomy

    F. Hernandez-Fernandez, R. Martinez-Fernandez, J.U Mañez-Miro, P. Martinez-Martin, J.A Obeso (Móstoles, Spain)

    Objective: To analyze the improvement in quality of life (QOL) and treatment´s satisfaction patients with essential tremor (ET) treated with HIFU thalamotomy. Background: Tremor is…
  • MDS Virtual Congress 2020

    The Role of Directional Configuration for Essential Tremor: A Single Center Experience

    V. Veerappan, A. Hiller (Portland, OR, USA)

    Objective: To describe the programming criteria and patient characteristics for use of directional versus omnidirectional configurations for deep brain stimulation (DBS) in patients with Essential…
  • MDS Virtual Congress 2020

    An Open-Label, Phase 1b Study of the Neuroactive Steroid GABAA Receptor Positive Allosteric Modulator SAGE-324 in Essential Tremor

    H. Colquhoun, D. Nguyen, M. Qin, A. Wehr, J. Doherty, S. Kanes (Cambridge, MA, USA)

    Objective: This single dose, open-label, Phase 1b study assessed the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SAGE-324 in otherwise healthy patients with Essential…
  • MDS Virtual Congress 2020

    Cortical network fingerprint and prediction of deep brain stimulation-induced speech impairment in essential tremor

    J.N Petry-Schmelzer, H. Jergas, T. Thies, J. Steffen, P. Reker, H. Dafsari, D. Mücke, G. Fink, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To gain insights into brain areas associated with stimulation-induced dysarthria (SID) and to predict stimulation-induced worsening of intelligibility in essential tremor (ET) patient with…
  • MDS Virtual Congress 2020

    Efficacy and safety of CX-8998 in T-CALM, a randomized, double-blind, placebo-controlled, phase 2a trial in participants with essential tremor: subgroup analysis by baseline tremor severity

    H. Jinnah, S. Papapetropoulos, M. Lee, S. Versavel, E. Newbold, R. Pahwa, K. Lyons, R. Elble, W. Ondo, T. Zesiewicz, P. Hedera, A. Handforth, J. Elder, M. Versavel (Atlanta, GA, USA)

    Objective: Evaluate efficacy and safety of CX-8998 in essential tremor (ET) as a function of baseline tremor severity. Background: CX-8998, a selective modulator of T-type…
  • MDS Virtual Congress 2020

    Quantitative Tremor Analysis of Functional Tremor

    F. Zhang, R. Tripathi (San Diego, CA, USA)

    Objective: To compare the characteristic frequency of functional tremor with other tremor disorders using 3-D motion analysis and kinematics. Background: Functional tremor (FT) is a…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 45
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley